SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000919574-24-000965
Filing Date
2024-02-13
Accepted
2024-02-13 12:29:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 d10963563_13g-a.htm SC 13G/A 120713
  Complete submission text file 0000919574-24-000965.txt   122430
Mailing Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022 2127025204
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001569064 (see all company filings)

IRS No.: 453704500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Subject) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91349 | Film No.: 24623978
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)